Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$53.43 - $68.12 $62,940 - $80,245
-1,178 Reduced 20.96%
4,442 $274,000
Q4 2022

Feb 13, 2023

BUY
$61.23 - $83.62 $7,408 - $10,118
121 Added 2.2%
5,620 $357,000
Q3 2022

Nov 14, 2022

SELL
$65.58 - $84.69 $142,308 - $183,777
-2,170 Reduced 28.3%
5,499 $399,000
Q2 2022

Aug 12, 2022

SELL
$52.13 - $93.81 $57,030 - $102,628
-1,094 Reduced 12.48%
7,669 $521,000
Q1 2022

May 13, 2022

BUY
$64.92 - $99.47 $568,893 - $871,655
8,763 New
8,763 $794,000
Q4 2021

Feb 11, 2022

SELL
$76.51 - $93.96 $191,734 - $235,463
-2,506 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$71.29 - $95.99 $178,652 - $240,550
2,506 New
2,506 $203,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.52B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.